Supporting international networks through platforms for standardised data collection—the European Registries for Rare Endocrine Conditions (EuRRECa) model

Ali, S.R., Bryce, J. , Smythe, C., Hytiris, M., Priego, A.L., Appelman-Dijkstra, N.M. and Ahmed, S.F. (2021) Supporting international networks through platforms for standardised data collection—the European Registries for Rare Endocrine Conditions (EuRRECa) model. Endocrine, 71(3), pp. 555-560. (doi: 10.1007/s12020-021-02617-0) (PMID:33512655) (PMCID:PMC7844549)

[img] Text
228158.pdf - Published Version
Available under License Creative Commons Attribution.

520kB

Abstract

Rare endocrine pathology is manifested by either a deficiency or excess of one or more hormones. These conditions can be life-threatening and are almost universally associated with long-term morbidity. Understanding the aetiology of these conditions requires multicentre collaboration and expertise, most often across national boundaries, with the capacity for long-term follow-up. The EuRRECa (European Registries for Rare Endocrine Conditions) project (www.eurreca.net), funded by the EU Health Programme, aims to support the needs of the wider endocrine community by maximising the opportunity for collaboration between patients, health care professionals and researchers across Europe and beyond. At the heart of the EuRRECa collaboration is a Core Endocrine Registry that collects a core dataset for all rare endocrine conditions that are covered within Endo-ERN. The registry incorporates patient reported markers of clinical outcome and will signpost participants to high-quality, disease-specific registries. Furthermore, an electronic surveillance programme (e-REC) captures clinical activity and epidemiology for these rare conditions. EuRRECa receives guidance compliant with the highest ethical standards from Expert Working Groups that align with the Main Thematic Groups of Endo-ERN. Security, data quality and data governance are cornerstones of this platform. Clear policies that are acceptable to patients, researchers and industry for data governance coupled with widespread dissemination and knowledge exchange through closely affiliated stakeholders will ensure sustainability beyond the current lifetime of the project. This paper describes the infrastructure that has been developed, stakeholder involvement, the data fields that are captured within the registry and details on the process for using the platform.

Item Type:Articles
Additional Information:SFA and JB are supported by the European Union’s Health Programme (2014–2020) on the EuRRECa project ‘777215/EuRRECa’. SFA and NA-D are supported by the European Union’s Health Programme (2014–2020) on the EuRR-Bone project ‘946831/EuRR-Bone’.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Ahmed, Professor Syed Faisal and Bryce, Dr Jillian and Ali, Dr Salma and Hytiris, Dr Monica and Priego Zurita, Dr Ana and Smythe, Mr Christopher
Authors: Ali, S.R., Bryce, J., Smythe, C., Hytiris, M., Priego, A.L., Appelman-Dijkstra, N.M., and Ahmed, S.F.
College/School:College of Medical Veterinary and Life Sciences > School of Medicine, Dentistry & Nursing
Journal Name:Endocrine
Publisher:Springer
ISSN:1355-008X
ISSN (Online):1559-0100
Published Online:29 January 2021
Copyright Holders:Copyright © 2021 The Authors
First Published:First published in Endocrine 71(3): 555-560
Publisher Policy:Reproduced under a Creative Commons license

University Staff: Request a correction | Enlighten Editors: Update this record